|
2024-01-31 |
2024-01-29 |
PS
Planned sale
|
Vasquez Nicki
CHIEF PORT. STRAT & ALNCE OFCR
Officer
|
12,185
-48.8%
5.00
USD 60,925
|
12,185
-48.8%
|
5.00
|
USD 60,925
|
|
|
2023-08-29 |
2023-08-28 |
PS
Planned sale
|
Shtylla Brunilda
Chief Business Officer
Officer
|
15,428
-100.0%
4.71
USD 72,595
|
15,428
-100.0%
|
4.71
|
USD 72,595
|
|
|
2023-08-28 |
2023-08-25 |
S
Sale
|
Shtylla Brunilda
Chief Business Officer
Officer
|
11,613
-47.3%
4.59
USD 53,282
|
11,613
-47.3%
|
4.59
|
USD 53,282
|
|
|
2022-03-15 |
2022-03-14 |
B
Purchase
|
NEWELL WILLIAM J
CEO
Executive Director
|
10,000
+9.4%
7.75
USD 77,508
|
10,000
+9.4%
|
7.75
|
USD 77,508
|
|
|
2021-09-28 |
2021-09-28 |
PS
Planned sale
|
Vasquez Nicki
Chief Port. Strat & Alnce Ofcr
Officer
|
3,906
-34.9%
18.62
USD 72,724
|
3,906
-34.9%
|
18.62
|
USD 72,724
|
|
|
2021-01-27 |
2021-01-26 |
PS
Planned sale
|
Hallam Trevor
Chief Scientific Officer
Officer
|
165
-0.3%
26.10
USD 4,306
|
165
-0.3%
|
26.10
|
USD 4,306
|
|
|
2021-01-27 |
2021-01-26 |
PS
Planned sale
|
Hallam Trevor
Chief Scientific Officer
Officer
|
2,228
-3.8%
25.68
USD 57,222
|
2,228
-3.8%
|
25.68
|
USD 57,222
|
|
|
2020-12-29 |
2020-12-28 |
PS
Planned sale
|
Hallam Trevor
Chief Scientific Officer
Officer
|
2,393
-6.1%
22.37
USD 53,530
|
2,393
-6.1%
|
22.37
|
USD 53,530
|
|
|
2020-11-30 |
2020-11-27 |
PS
Planned sale
|
Hallam Trevor
Chief Scientific Officer
Officer
|
2,393
-6.1%
17.01
USD 40,713
|
2,393
-6.1%
|
17.01
|
USD 40,713
|
|
|
2020-11-06 |
2020-11-05 |
PS
Planned sale
|
Hallam Trevor
Chief Scientific Officer
Officer
|
16,751
-31.3%
15.00
USD 251,265
|
16,751
-31.3%
|
15.00
|
USD 251,265
|
|
|
2020-09-28 |
2020-09-28 |
PS
Planned sale
|
Hallam Trevor
Chief Scientific Officer
Officer
|
975
-3.4%
10.26
USD 10,007
|
975
-3.4%
|
10.26
|
USD 10,007
|
|
|
2020-09-22 |
2020-09-18 |
S
Sale
|
Freund John Gordon
Non-Executive Director
|
400,000
-41.7%
12.00
USD 4,800,000
|
400,000
-41.7%
|
12.00
|
USD 4,800,000
|
|
|
2020-09-15 |
2020-09-11 |
S
Sale
|
Freund John Gordon
Non-Executive Director
|
500,000
-34.2%
10.00
USD 5,000,000
|
500,000
-34.2%
|
10.00
|
USD 5,000,000
|
|
|
2020-08-27 |
2020-08-26 |
PS
Planned sale
|
Hallam Trevor
Chief Scientific Officer
Officer
|
975
-5.5%
9.04
USD 8,818
|
975
-5.5%
|
9.04
|
USD 8,818
|
|
|
2020-08-21 |
2020-08-19 |
S
Sale
|
Freund John Gordon
Non-Executive Director
|
500,000
-25.5%
8.72
USD 4,360,000
|
500,000
-25.5%
|
8.72
|
USD 4,360,000
|
|
|
2020-07-28 |
2020-07-27 |
PS
Planned sale
|
Hallam Trevor
Chief Science Officer
Officer
|
975
-5.2%
8.06
USD 7,858
|
975
-5.2%
|
8.06
|
USD 7,858
|
|
|
2020-05-27 |
2020-05-26 |
PS
Planned sale
|
Hallam Trevor
Chief Science Officer
Officer
|
975
-4.7%
10.00
USD 9,753
|
975
-4.7%
|
10.00
|
USD 9,753
|
|
|
2020-05-14 |
2020-05-14 |
B
Purchase
|
NEWELL WILLIAM J
CEO
Executive Director
|
64,516
+63.2%
7.75
USD 499,999
|
64,516
+63.2%
|
7.75
|
USD 499,999
|
|
|
2020-05-14 |
2020-05-14 |
B
Purchase
|
MOLINA ARTURO MD
Chief Medical Officer
Officer
|
6,451
+114.5%
7.75
USD 49,995
|
6,451
+114.5%
|
7.75
|
USD 49,995
|
|
|
2020-05-14 |
2020-05-14 |
B
Purchase
|
FITZPATRICK LINDA A
Chief People & Comm. Officer
Officer
|
3,225
+55.8%
7.75
USD 24,994
|
3,225
+55.8%
|
7.75
|
USD 24,994
|
|
|
2020-04-27 |
2020-04-27 |
PS
Planned sale
|
Hallam Trevor
Chief Science Officer
Officer
|
2
-0.0%
11.19
USD 22
|
2
-0.0%
|
11.19
|
USD 22
|
|
|
2020-04-27 |
2020-04-27 |
PS
Planned sale
|
Hallam Trevor
Chief Science Officer
Officer
|
973
-4.5%
9.41
USD 9,161
|
973
-4.5%
|
9.41
|
USD 9,161
|
|
|
2020-03-27 |
2020-03-26 |
PS
Planned sale
|
Hallam Trevor
Chief Science Officer
Officer
|
975
-4.3%
9.69
USD 9,453
|
975
-4.3%
|
9.69
|
USD 9,453
|
|
|
2020-02-27 |
2020-02-26 |
PS
Planned sale
|
Hallam Trevor
Chief Science Officer
Officer
|
975
-4.1%
10.47
USD 10,207
|
975
-4.1%
|
10.47
|
USD 10,207
|
|
|
2020-01-28 |
2020-01-27 |
PS
Planned sale
|
Hallam Trevor
Chief Science Officer
|
975
-4.0%
10.51
USD 10,250
|
975
-4.0%
|
10.51
|
USD 10,250
|
|
|
2019-12-27 |
2019-12-26 |
PS
Planned sale
|
Hallam Trevor
Chief Science Officer
Officer
|
975
-3.8%
11.08
USD 10,802
|
975
-3.8%
|
11.08
|
USD 10,802
|
|
|
2019-11-27 |
2019-11-26 |
PS
Planned sale
|
Hallam Trevor
Chief Science Officer
|
975
-3.7%
10.68
USD 10,410
|
975
-3.7%
|
10.68
|
USD 10,410
|
|
|
2019-10-30 |
2019-10-28 |
PS
Planned sale
|
Hallam Trevor
Chief Science Officer
|
975
-3.5%
9.98
USD 9,726
|
975
-3.5%
|
9.98
|
USD 9,726
|
|
|
2018-10-02 |
2018-10-01 |
B
Purchase
|
Merck & Co., Inc.
Large shareholder
|
666,666
+32.4%
15.00
USD 9,999,990
|
666,666
+32.4%
|
15.00
|
USD 9,999,990
|
|
|
2018-10-01 |
2018-10-01 |
S
Sale
|
Petree Daniel H
Non-Executive Director
|
122
-38.9%
15.00
USD 1,830
|
122
-38.9%
|
15.00
|
USD 1,830
|
|
